Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:59 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 2,006 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Discrete Clear all

Conditions: Stroke
Interventions: Exercise, Behavioral Management Program; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 89 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cirrhosis
Interventions: BCAA Supplement, Physical Activity; Dietary Supplement · Other
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Diffuse Intrinsic Pontine Glioma (DIPG)
Interventions: Melphalan hydrochloride; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 1 Month to 17 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Eating Disorders, Binge Eating, Purging (Eating Disorders), Bulimia Nervosa, Anorexia Nervosa, Atypical
Interventions: Naltrexone, Placebo; Drug
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 13 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Ischemia Reperfusion Injury
Interventions: recombinant P-selectin glycoprotein ligand Ig fusion protein, Viaspan® and saline; Drug
Lead sponsor: Y's Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cardiac Rehabilitation
Interventions: Progressive High Intensity Interval Training (PRO-HIIT), Constant High Intensity Interval Training (CON-HIIT); Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Family, Critical Care, Mobile Applications
Interventions: ICU-Care; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Corneal Opacity, Keratoconus
Interventions: LALAK, IEK, Retrobulbar Block or General Anesthesia, optical coherence tomography (OCT), Topical Anesthesia, femtosecond laser; Procedure · Drug · Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Type2 Diabetes, Medication Adherence, Medication Nonadherence, Peer Support
Interventions: Peers Supporting Health-Literacy, Self Efficacy, Advocacy and Adherence; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 30 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Major Depressive Disorder
Interventions: LY2216684, Digoxin; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Daytona Beach, Florida

Conditions: Headache Disorders, Primary, Headache, Cervicogenic
Interventions: Dry needling; Other
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Heart Failure With Reduced Ejection Fraction
Interventions: PRIME, COMBO; Other
Lead sponsor: University of Virginia; Other
Eligibility: 65 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Pharmacokinetics, Tolerability
Interventions: Androxal, Placebo; Drug
Lead sponsor: Repros Therapeutics Inc.; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Cognitive Performance
Interventions: fMRI with virtual reality flight simulator; Diagnostic Test
Lead sponsor: The Geneva Foundation; Other
Eligibility: 18 Years to 54 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Sprains and Strains
Interventions: Passive Positioning, High-Velocity, Low-Amplitude Stretch, Slow, Mobilization Stretch; Other
Lead sponsor: University of the Pacific; Other
Eligibility: 16 Years to 60 Years
Enrollment: 189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Stockton, California

Conditions: Obesity
Interventions: Fecal Sample Collection, Physical Activity Questionnaire, Food Frequency Questionnaire, 24-hour dietary recall diary; Other
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 6 Years to 12 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Duchenne Muscular Dystrophy
Interventions: NS-065/NCNP-01; Drug
Lead sponsor: NS Pharma, Inc.; Industry
Eligibility: 4 Years to 10 Years · Male only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 5
States / cities: Sacramento, California • Chicago, Illinois • St Louis, Missouri + 2 more

Conditions: Carotid Artery Diseases
Interventions: Transcarotid Artery Revascularization (TCAR); Procedure
Lead sponsor: Silk Road Medical; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 37
States / cities: Huntsville, Alabama • Scottsdale, Arizona • Tucson, Arizona + 33 more

Conditions: Advanced Solid Tumors
Interventions: BAY3375968, Pembrolizumab; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 4
States / cities: Chicago, Illinois • Chapel Hill, North Carolina • San Antonio, Texas + 1 more

Conditions: Educational Intervention, Minorities
Interventions: Educational Intervention; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Memory Disorders
Interventions: Insulin, Saline; Drug · Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 21 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Austin, Texas

Conditions: PTSD, Chronic Pain
Interventions: Stellate Ganglion Block, Cognitive Processing Therapy; Procedure · Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 345 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Solid Tumor, Hematological Malignancy
Interventions: Locus Health iPhone App; Device
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Solid Tumor, NSCLC, Colorectal Cancer, Head and Neck Cancer, Cholangiocarcinoma
Interventions: [225Ac]Ac-FL-261; Drug
Lead sponsor: Full-Life Technologies UK Limited; Industry
Eligibility: 18 Years and older
Enrollment: 208 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Self-Managed Exercise in Chronic Stroke

BCAA Supplemental Study

Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).

Naltrexone Neuroimaging in Teens With Eating Disorders

YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation

A Study to Compare the Effectiveness of Different High-intensity Interval Training Programs in Cardiac Rehabilitation

Mobile App to Promote Family Caregiver Engagement in the Intensive Care Unit

OCT-guided LALAK for KCN

Improving Diabetes Medication Adherence for African Americans in Madison and Milwaukee Through Peer Support

A Study of LY2216684 and Digoxin in Healthy Subjects

Effect of Ultrasound-Guided Dry Needling Targeting Rectus Capitus Posterior Major on Individuals With Headaches

PRIME HFrEF: Novel Exercise for Older Patients With Heart Failure With Reduced Ejection Fraction

A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal

Determining Which Regions of the Brain Are Active During Flight Simulation at Separate Timepoints During Training

Ankle Manual Therapy for Ankle Sprains

Gut Microbiota Composition in Hispanic and Non-Hispanic Children.

Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)

ROADSTER 3 Extended Follow-up Sub-Study

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities

Mechanisms of Insulin Facilitation of Memory

Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset

A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET